Small Solutions for Big Problems: The Application of Nanoparticles to Brain Tumor Diagnosis and Therapy
- 25 February 2009
- journal article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 85 (5), 531-534
- https://doi.org/10.1038/clpt.2008.296
Abstract
Nanotechnology has been projected to have a significant impact on the future treatment of brain tumors. Specifically, nanoparticles have the potential to revolutionize brain tumor imaging as well as surgical and adjuvant treatments. The translation of current research in nanotechnology into clinical practice will rely on solving challenges relating to the pharmacology of nanoparticles. Clinical Pharmacology & Therapeutics (2009); 85, 5, 531–534 doi:10.1038/clpt.2008.296Keywords
This publication has 102 references indexed in Scilit:
- Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumorsBiomaterials, 2008
- In Vivo MRI Detection of Gliomas by Chlorotoxin‐Conjugated Superparamagnetic NanoprobesSmall, 2008
- Renal clearance of quantum dotsNature Biotechnology, 2007
- Molecularly targeted therapy for malignant gliomaCancer, 2007
- Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model1Neuro-Oncology, 2006
- Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trialThe Lancet Oncology, 2006
- Fluorescent Nanoparticle Uptake for Brain Tumor VisualizationNeoplasia, 2006
- Effectiveness of neuronavigation in resecting solitary intracerebral contrast-enhancing tumors: a randomized controlled trialJournal of Neurosurgery, 2006
- Intra-operative magnetic resonance imaging in neurosurgeryActa Neurochirurgica, 2004
- Intravenous Administration to Rabbits of Non-stealth and Stealth Doxorubicin-loaded Solid Lipid Nanoparticles at Increasing Concentrations of Stealth Agent: Pharmacokinetics and Distribution of Doxorubicin in Brain and Other TissuesJournal of Drug Targeting, 2002